Skip to main content
Smart Investors Daily
Henry Schein, Inc. logo

NASDAQ · HSIC

Henry Schein, Inc.

Healthcare · Medical - Distribution

$87.52

Down-$1.41 (-1.59%)

Updated Sep 16, 2026, 11:29 AM

SID Score

6.0/10

Composite research score

Smart Money

58/100

Neutral

Market cap
9.35B
P/E ratio
23.9
Dividend yield
0.00%
52-week range
$68.70 – $92.18
Volume
1.55M
Avg. volume
1.51M

Price performance

HSIC price history

1M range · 20 trading sessions · Daily adjusted prices

HSIC closed at $87.52 after 20 trading sessions, down 1.92% for the selected period.

Last close
$87.52
Period change
-1.92%
Period low
$87.30
Period high
$90.86
Daily close
View OHLC price history
HSIC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 15, 2026$88.93$88.93$87.26$87.521.55M
Sep 14, 2026$88.57$89.115$87.645$88.93818.39K
Sep 11, 2026$88.54$88.79$87.36$88.36713.85K
Sep 10, 2026$88.20$88.22$87.11$87.301.54M
Sep 9, 2026$88.14$88.92$87.65$87.97768.11K
Sep 8, 2026$89.50$89.99$88.7101$88.86711.85K
Sep 4, 2026$89.91$90.54$89.645$89.81887.87K
Sep 3, 2026$90.68$91.69$89.56$90.86679.34K
Sep 2, 2026$89.02$91.36$88.605$90.39859.39K
Sep 1, 2026$89.80$90.15$88.00$88.52718.25K
Aug 31, 2026$88.93$90.00$88.1638$89.801.15M
Aug 28, 2026$90.54$91.09$89.47$89.52795.97K
Aug 27, 2026$90.30$91.39$89.605$90.28784.93K
Aug 26, 2026$89.97$90.67$89.49$90.38697.17K
Aug 25, 2026$89.19$89.84$88.74$89.65819.51K
Aug 24, 2026$88.50$89.7102$87.67$89.51669.18K
Aug 21, 2026$88.74$89.11$88.19$88.50758.82K
Aug 20, 2026$89.00$89.69$88.405$88.46865.71K
Aug 19, 2026$90.11$91.29$89.17$89.291.18M
Aug 18, 2026$89.94$90.455$88.73$89.231.03M

Latest HSIC news

The latest Smart Investors Daily articles mentioning HSIC.

HSIC research

Overview

Company profile and research snapshot.

Company profile

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$82.50
Implied upside
Analysts
HSIC recent ratings
DateFirmRatingTarget
Aug 19, 2026BTIGBuy
Aug 6, 2026BarclaysOverweight
Aug 5, 2026CitigroupBuy
Aug 5, 2026UBSNeutral
Aug 5, 2026BTIGBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 9, 2026

DermaSensor Raises $5 Million and Opens Round to the Public via Wefunder, Alongside Four Major New US Partnerships

MIAMI, September 09, 2026--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, announced today the close of a $4M Series B extension, including institutional and strategic investors, alongside the launch of a community investment round on Wefunder. This new community financing has already raised more than $1 million at the same terms as the $4M. This follows the company’s $16M Series B, closed in 2025, and brings the total investment in the company to $48 million.

Yahoo · Sep 2, 2026

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.